The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
April 15th 2025
Strategies for rescuing PTPRD function in diseased livers could provide potential therapeutic options, wrote the study authors.
US Residents of Mexican Descent Show Higher Liver Cancer Risk in Successive Generations
September 20th 2022Second- and third-generation individuals living in Los Angeles, California, demonstrate 35% and 61%, respectively, more of a chance of getting the disease, according to new study results.
Read More
Study: Climate Hazards Aggravate More than Half of Human Diseases Caused by Pathogens
August 25th 2022Climatic hazards were implicated for enhancing specific aspects of pathogens, increasing capacity of pathogens to cause more severe illness, and diminishing human capacity to cope with pathogens, such as dengue, hepatitis, pneumonia, malaria, and zika.
Read More
Pediatric Hepatitis Levels Remain Consistent With Pre-Pandemic Levels
July 12th 2022Hepatitis-associated emergency department visits and hospitalizations, liver transplantations, and adenovirus stool testing results in pediatric patients were not found to increase during the COVID-19 pandemic.
Read More